市場調查報告書
商品編碼
1499971
全球一次性組裝市場評估:依產品、解決方案、應用、最終用途、地區、機會和預測(2017-2031)Single-Use Assemblies Market Assessment, By Product, By Solution, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
全球一次性組裝市場規模預計將從 2023 年的 36.9 億美元增至 2031 年的 127.2 億美元,預計 2024-2031 年的複合年增長率為 16.73%。市場成長的推動因素包括製藥和生物製藥行業的快速成長、生物製品投資的增加、新產品和新技術的推出、加快藥物開發進程的活動不斷增加以及傳染病的流行。
公司增加將藥物快速推向市場的活動是全球一次性組裝市場的主要趨勢之一。 2024 年 4 月,SaniSure Limited 推出了 Fill4Sure,這是一種客製化的一次性填充組件,可提高藥品填充流程的可重複性、安全性和效率。高性能管材、矽膠包覆成型、低顆粒 2D 緩衝袋、無黏合劑/無油 OEM 以及客製化設計的針頭等功能可最大限度地降低污染風險並確保產品純度。這些先進功能也簡化了生物加工和生物製造流程,幫助製造商確保供應鏈安全並擴大生產能力。這些經濟高效、量身定制的效率可幫助您輕鬆擴展規模,以滿足行業不斷變化的需求。
增加對生物製品的投資也預計將促進市場成長。 2024年1月,AbbVie宣佈將投資2.23億美元擴建其在新加坡的生物製劑生產設施。擴建預計於2026年完成,新增生物製劑產能24,000公升,並新增100個就業機會。該投資預計將支持該公司在全球擴張製造網絡,並支持其癌症和免疫學產品線。此外,一次性組件也用於生物製藥製造領域的各個階段,包括中間製程儲存、培養基和緩衝液製備、下游加工和上游加工。
研發活動的增加刺激了市場需求
全球各地區患有傳染病和慢性病的患者數量不斷增加,對需要一次性組裝的疫苗的需求不斷增加。這促使對疫苗生產的投資增加,以減少與傳染病相關的有害影響,根除天花等嚴重病毒和病原體,並降低兒童死亡率。美國國立衛生研究院 (NIH) 等各種政府機構、慈善基金會以及比爾和梅琳達蓋茲基金會和歐盟委員會等超國家機構也在資助疫苗研發活動。根據世界衛生組織(WHO)估計,2021年將供應1,410億美元和約160億劑疫苗。這些因素推動了對一次性組件的需求,因為它們透過減少清潔和停機時間來提高成本效率,並最大限度地降低因污染而導致產品損失的風險。
新產品的推出支持市場成長
增加開發有助於簡化工作流程並實現快速部署的新產品的活動是全球一次性組裝市場的關鍵成長動力之一。 2022 年 3 月,多佛公司推出了用於處理無菌液體的一次性液體生物處理袋。該公司還擴大了粉末(預填充和非預填充)和無菌液體產品的供應範圍。該公司的供應聲譽、全球足跡和品質確保其能夠大規模、快速地滿足客戶不斷變化的需求。
這些發展預計將透過提供根據客戶獨特需求量身定制的全面解決方案來增加全球一次性組裝市場的需求。它們還透過提供易於部署且價格實惠的技術先進產品和創新解決方案,對市場成長產生積極影響。
本報告研究和分析了全球一次性組裝市場,提供市場規模和預測、市場動態以及主要參與者的現狀和前景。
Global single-use assemblies market is projected to witness a CAGR of 16.73% during the forecast period 2024-2031F, growing from USD 3.69 billion in 2023 to USD 12.72 billion in 2031F. The market's growth is augmented by the rapid growth of the pharmaceutical and biopharmaceutical sectors, increasing investments towards biologics, the introduction of novel products and technologies, growing efforts to expedite the drug development process, and the increasing prevalence of infectious diseases.
Rising efforts by companies to expedite drugs to market are among the major global single-use assembly market trends. In April 2024, SaniSure Limited launched Fill4Sure, a custom single-use filling assembly to increase drug product filling processes' repeatability, safety, and efficiency. Features such as high-performance tubing, silicone over-molding, low-particulate 2D surge bags, adhesive and oil-free OEM, and custom-designed needles ensure product purity by minimizing contamination risks. These advanced features also streamline bioprocessing and biomanufacturing processes, aiding the manufacturer in securing supply chains and expanding their capacity. Such cost-efficient and tailor-made efficiencies aid in effortless scaling up to meet the industry's evolving requirements.
Increasing investments in biologics are also expected to aid the market's growth. In January 2024, AbbVie Inc. announced an investment of USD 223 million to expand their Singapore biologics manufacturing facility. The expansion is expected to conclude in 2026 and add 24,000 liters of biologics drug-substance capacity and 100 new jobs. This investment is expected to aid the expansion of the company's manufacturing network globally and support its oncology and immunology pipeline. Additionally, single-use assemblies are used in various stages in the biologics manufacturing sector, including process-intermediate storage, media and buffer preparation, downstream processing, and upstream processing.
Increasing Research and Development Activities Boost Market Demand
The rise in infectious and chronic disease cases in various regions across the globe is propelling the requirement for vaccines, which require single-use assemblies. Due to this, the investments in the production of vaccines are increasing as they aid in reducing the detrimental effects associated with infectious diseases, eradicate major viruses and pathogens, such as smallpox, and decrease child mortality rates. Various government agencies such as the National Institute of Health (NIH), philanthropic foundations and supranational bodies, including the Bill and Melinda Gates Foundation and the European Commission, are also financing vaccine research and development activities. According to estimates from the World Health Organization (WHO), vaccines worth USD 141 billion, approximately 16 billion doses, were supplied in 2021. These factors boost the demand for single-use assemblies as they offer cost efficiency due to reduced cleaning and downtime and minimize the risk of product loss due to contamination.
New Product Launches Support Market Growth
Rising efforts to develop novel products that aid in streamlining workflow while allowing for rapid implementation are one of the major factors bolstering the global single-use assemblies market growth. In March 2022, Dover Corporation launched its liquid single-use bioprocessing bags for handling sterile liquids. The company is also expanding its powder (pre-filled and non-pre-filled) and sterile liquid offerings. Their supply reputation, global footprint, and quality ensure that they can meet the customers' evolving requirements at scale and speed.
Such developments are expected to propel the global single-use assemblies market demand as they allow companies to provide comprehensive solutions tailored to the customer's unique requirements. They also allow for the availability of technologically advanced products and ready-to-implement, affordable, and innovative solutions, thus positively influencing the market's growth.
North America Accounts for Significant Market Share
The market growth in North America is supported by the expansion of the pharmaceutical sector, increasing prevalence of infectious and chronic diseases, and rising emphasis on drug discovery research. Single-use assemblies find applications in patient delivery systems, cell cultivation, lab and drug discovery, and downstream and upstream bioprocessing.
The increasing awareness about the various advantages associated with using single-use assemblies as opposed to their counterparts is also supporting the expansion of the market in North America. Traditionally, process equipment is made of stainless steel, among other metals, and has high maintenance and upfront costs.
The rapid growth of the biotechnology industry in the United States is also expected to offer lucrative growth opportunities to the market as single-use assemblies find applications in various biotechnology domains, such as cell and gene therapy. According to estimates from the Council of State Bioscience Associations (CSBA) and Biotechnology Innovation Organization (BIO), the bioscience industry in the United States was valued at USD 2.9 trillion in 2021.
Pharmaceutical and Biopharmaceutical Companies Hold Significant Market Share
The rapid expansion of the pharmaceutical and biopharmaceutical sectors, owing to the increasing prevalence of various chronic and infectious diseases, supports the segment's growth. The increasing investments by major companies in developing new facilities to combat this growing threat bolstered the market's demand. Single-use assemblies reduce the risk of cross-batch and cross-product contamination and provide a smaller manufacturing footprint. Various sterile sectors, including pharmaceutical and biopharmaceutical sectors, have shifted to single-use assemblies and technologies at some time for a few applications, if not all, over the past few years as they aid in improving facility adaptability and flexibility and increase product integrity.
In February 2024, Thermo Fisher Scientific Inc. announced the opening of its new sterile drug facility in Singapore to ensure the delivery of new vaccines and medicines to the Asia Pacific market. The facility has been established with assistance from the Singapore Economic Development Board (EDB) and is in alignment with the efforts of the government to prepare for health emergencies that can emerge in the future. The increasing development of such facilities is expected to propel the requirement for single-use assemblies in the coming years, owing to their various advantages.
Future Market Scenario (2024-2031F)
According to the global single-use assemblies market analysis, the expansion of the pharmaceutical sector, coupled with increasing investments in research and development activities, is expected to bolster the market's demand in the coming years. Features such as reduced environmental impact, faster turnaround and changeover times, high flexibility, and reduced risk of product loss and cross-contamination are expected to propel the utilization of single-use assemblies in the coming years. Continuous efforts of key market players to enhance leak resistance and strength of single-use assemblies are also expected to provide lucrative growth opportunities to the market.
Key Players Landscape and Outlook
New launches by the key market players are bolstering the global single-use assemblies market size. In April 2023, Merck & Co., Inc. launched Ultimus films to provide leak resistance and superior strength in single-use assemblies used in bioprocessing liquid applications. The film is designed using a proprietary woven nylon structure to provide protection against fatigue, tears, leaks, and abrasion, as well as improved resilience and durability and enhanced bag strength. Incorporating woven nylon also provides ease of handling, conformity, and flexibility, which are essential for single-use processing. Such developments are expected to offer lucrative growth opportunities to the market in the coming years as they provide durable and stronger solutions to end-users while minimizing disruptions and increasing operational efficiency.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work